Chapter 11. Preclinical Testing of Antibodies: Safety Aspects

  1. Prof. Dr. H.-J. Rehm2 and
  2. Dr. G. Reed3
  1. Ronald W. James

Published Online: 7 MAY 2008

DOI: 10.1002/9783527620999.ch11d

Biotechnology Set, Second Edition

Biotechnology Set, Second Edition

How to Cite

James, R. W. (2001) Preclinical Testing of Antibodies: Safety Aspects, in Biotechnology Set, Second Edition (eds H.-J. Rehm and G. Reed), Wiley-VCH Verlag GmbH, Weinheim, Germany. doi: 10.1002/9783527620999.ch11d

Editor Information

  1. 2

    Institut für Mikrobiologie, Universität Münster, Corrensstraße 3, D-4400 Münster

  2. 3

    2131 N. Summit Ave., Apartment #304, Milwaukee, WI 53202-1347, USA

Author Information

  1. Huntingdon, UK

Publication History

  1. Published Online: 7 MAY 2008
  2. Published Print: 10 MAY 2001

ISBN Information

Print ISBN: 9783527257621

Online ISBN: 9783527620999

SEARCH

Keywords:

  • modulation;
  • theoretical;
  • synthesized;
  • toxicological;
  • therapeutic

Summary

The prelims comprise:

  • Introduction

  • Regulatory Testing Requirements

  • Timing of Studies in Relation to Clinical Trials

  • Tissue Specificity and Cross-Reactivity

  • Pharmaco-Toxicological Testing